Trial Profile
A Double- Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Antiviral Activity of Clevudine 30 Mg QD and 50 Mg QD Doses in Patients Infected With Hepatitis B Virus
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Clevudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Bukwang Pharmaceutical
- 16 Nov 2006 New trial record.